Since 2018, Biozenta delivers affordable, research-driven oncology and critical care medicines — improving lives globally with innovation, trust, and world-class quality.
Years Of Experience
Trusted By
Oncology
Critical Care
API Development
Research & Innovation
Manufacturing
Quality Control
Global Presence
Regulatory Support
Sustainability
Oncology
Critical Care
API Development
Research & Innovation
Manufacturing
Quality Control
Global Presence
Regulatory Support
Sustainability
Biozenta was founded in 2018 with a noble vision to make critical care medicines accessible and affordable, enabling people to lead healthier, happier, and more active lives.
In a short span of time, Biozenta has established itself as a trusted name in the global pharmaceutical industry, emerging as a leading manufacturer of high-quality pharmaceutical products, particularly in the Oncology and Critical Care segments.
Biozenta — Advancing Healthcare, Enriching Lives.
Working with international healthcare leaders and research institutions.
Learn More
Dr. Deep Narayan Sharma, Founder and Managing Director of the Biozenta Group of Companies, is a dynamic, ambitious, and accomplished technocrat with extensive experience in the pharmaceutical manufacturing industry.
A Master of Pharmacy (M.Pharm) with an MBA in Production Management, Dr. Sharma brings over 22 years of corporate and pharmaceutical industry experience, including leadership roles at senior and top-management levels. As a first-generation entrepreneur, he has built his journey on a strong foundation of passion, perseverance, focused execution, and an in-depth understanding of the pharmaceutical sector.
His core expertise and passion lie in Oncology, Anti-Cancer, Cytotoxic, Critical Care, and Life-Saving Products, with a particular focus on advanced drug-delivery technologies, including Nanoparticle and Liposomal technologies.
Driven by his entrepreneurial vision, Dr. Sharma established his first venture in 2011 — Dr. Aarbidee Laboratories and Aarya Healthcare, a division focused on food products. These ventures were subsequently merged with the Biozenta Group in 2018, marking an important milestone in the group's growth journey.
Under Dr. Sharma's visionary leadership and guiding principles, Biozenta has achieved significant milestones and expanded its portfolio of innovative pharmaceutical products, particularly across Oncology, Anti-Cancer, Cytotoxic, Critical Care, and Life-Saving segments.
Leadership Philosophy
Dr. Deep Narayan Sharma firmly believes in hard work, self-belief, leading by example, innovation, focused execution, and a passion for excellence. His philosophy of "Walk the Talk" reflects his commitment to turning vision into meaningful action.
These values form the foundation of Biozenta's organizational culture and inspire every member of the team to contribute towards the company's larger vision:
"Human Helping Human"
With a relentless commitment to innovation, quality, and human well-being, Dr. Sharma continues to lead Biozenta towards becoming a globally recognized pharmaceutical organization dedicated to making advanced healthcare solutions more accessible to those who need them most.
Our research is powered by expert teams and state-of-the-art technologies, ensuring precision, innovation, and real-world impact. Each field is explored with curiosity, guided by data, and focused on delivering meaningful solutions.
Advanced cancer-focused therapies and medicines ensuring better patient outcomes.
Comprehensive solutions for intensive care and life-saving treatments.
High-quality Active Pharmaceutical Ingredients for global healthcare needs.
Cutting-edge research driving continuous innovation in pharmaceuticals.
Biozenta Lifescience is committed to providing affordable, high-quality medicines in Oncology, Critical Care, APIs and General Injectables. With state-of-the-art manufacturing and DSIR approved R&D, we serve patients across 30+ countries with innovative and life-saving medicines.
Supplying to Asia, Africa, Europe, LATAM & GCC with strong regulatory approvals.
Manufacturing world-class Oncology, Anti-Cancer and Critical Care formulations including Injectables, Lyophilized, PFS, Tablets & Capsules.
WHO-cGMP, PICs approved and EU GMP approvable plants located in Una, Himachal Pradesh with dedicated Oncology and API units.
DSIR approved R&D labs specializing in formulation development, APIs and advanced technologies like Nano-particles, Liposomes & Monoclonal Antibodies.
Exporting to 30+ countries worldwide with 180+ international registrations and strong global collaborations.
Providing innovative, affordable oncology solutions to improve cancer care worldwide.
Supplying trusted general medicines that enhance everyday health and patient well-being.
Delivering safe, reliable injectable medicines for faster and effective therapeutic results.
Offering effective, patient-friendly tablets designed for consistent treatment and better compliance.
Manufacturing quality capsules to provide accurate dosage and improved patient satisfaction.
Biozenta Lifescience is a trusted name in the pharmaceutical industry with a strong presence across Oncology, Critical Care, APIs and General Injectables. With WHO-cGMP certified, PICs approved facilities and DSIR approved R&D, we deliver life-saving medicines that meet international standards.
Supplying to 30+ countries with 180+ product registrations across Asia, Africa, Europe, LATAM & GCC.
State-of-the-art WHO-cGMP certified and EU GMP approvable plants at Una, H.P. with dedicated Oncology and API units.
DSIR approved R&D labs and expertise in Nano-particle, Liposomal & Monoclonal Antibody technologies.
Biozenta – An Indian Global Pharmaceutical Company
Biozenta is a fast-growing Indian pharmaceutical manufacturer and exporter with a presence in 30+ countries across Asia, Africa, LATAM, CIS, MENA, and Europe. With 180+ international product registrations and several more underway, we actively participate in Government, MOH, and institutional tenders worldwide.
Commitment to Quality
Our mission is to deliver high-quality, affordable, and innovative healthcare solutions globally. Our R&D and Regulatory teams focus on diverse therapeutic segments, including Oncology, Anti-Cancer, Critical Care, Injectables, Oral Solids, ARVs, Derma, Cosmetics, and APIs.
Indian Excellence. Global Healthcare.
